key: cord-0954167-uuqviae4 authors: Franke, Gefion; Knobling, Birte; Brill, Florian H.; Becker, Britta; Klupp, Eva M.; Campos, Cristina Belmar; Pfefferle, Susanne; Lütgehetmann, Marc; Knobloch, Johannes K. title: An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2 date: 2021-04-15 journal: J Hosp Infect DOI: 10.1016/j.jhin.2021.04.007 sha: 368535472843e36266cbc38155988a88378e99b4 doc_id: 954167 cord_uid: uuqviae4 BACKGROUND: The presence of coronaviruses on surfaces in the patient environment is a potential source of indirect transmission. Manual cleaning and disinfection measures do not always achieve sufficient removal of surface contamination. This increases the importance of automated solutions in the context of final disinfection of rooms in the hospital setting. Ozone is a highly effective disinfectant which, combined with high humidity, is an effective agent against respiratory viruses. Current devices allow continuous nebulization for high room humidity as well as ozone production without any consumables. AIM: In the following study, the effectiveness of a fully automatic room decontamination system based on ozone was tested against bacteriophage Φ6 (phi 6) and bovine coronavirus L9, as surrogate viruses for the pandemic coronavirus SARS-CoV-2. METHODS: For this purpose, various surfaces (ceramic tile, stainless steel surface and furniture board) were soiled with the surrogate viruses and placed at two different levels in a gas-tight test room. After using the automatic decontamination device according to the manufacturer's instructions, the surrogate viruses were recovered from the surfaces and examined by quantitative cultures. Then, reduction factors were calculated. FINDINGS: The ozone-based room decontamination device achieved virucidal efficacy (reduction factor >4 log10) against both surrogate organisms regardless of the different surfaces and positions confirming a high activity under the used conditions. CONCLUSION: Ozone is highly active against SARS-CoV-2 surrogate organisms. Further investigations are necessary for a safe application and efficacy in practice as well as integration into routine processes. The spread of viruses with pandemic potential due to indirect contact transmission is controgested as a surrogate for coronaviruses [16] [17] [18] [19] After an incubation period of 24 to 48 hours' cells were lysed by a rapid freeze/thaw cycle. 118 Cellular debris was removed and the supernatant was mixed with bovine serum albumin 119 (BSA) (final concentration: 0.3 g/L BSA). After each experiment an endpoint dilution assay 120 was performed. Therefore, the treated and untreated carriers were rinsed with 1 mL medium 121 without fetal calf serum (FCS). Remaining infectivity was determined by transferring 0.1 mL 122 of appropriate tenfold serial dilutions into eight wells of a microtitre plate with a preformed 123 monolayer of U373 cells (10-15 x 10 3 cells per well), beginning with the highest dilution. Be-124 fore addition of virus, cells were washed twice with Eagle`s minimum essential medium 125 (EMEM) and incubated for 3 h with 100µL EMEM with trypsin. Microtitre plates were incubat-126 ed at 37 °C in a 5 % CO 2 -atmosphere. The cytopathic effect was read by using an inverted 127 microscope after five days and the infective dose TCID 50 /mL was calculated. The tested ozone room disinfection system represents a safe and useful additional disinfec-215 tion method that can be implemented after the discharge of patients infected with contagious 216 and environmentally resistant pathogens such as SARS-CoV-2. However, due to toxicity of 217 ozone, doors, ventilation diffusers must be strictly sealed to prevent unintentional dissemina-218 tion [24] , resulting in an additional work load for the operating person. Additionally, due to the 219 generated water aerosol smoke detectors must also be covered to avoid unwanted alarms. 220 During the disinfection cycle a concept is needed, to prevent unauthorized room entrance 221 during disinfection process. with anteroom and bathroom [37] . Furthermore, in order to achieve conditions that are as 235 close to reality as possible, we did not use standardized but realistic room conditions for the 236 untreated control panels that prevailed at the time of the test. Spontaneous reductions that 237 could be caused by temperature and humidity fluctuations will therefore not be excluded and Application of a novel decontamination process 321 using gaseous ozone Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models Selection of a Biosafety Level 1 (BSL-1) surrogate to evaluate 327 surface disinfection efficacy in Ebola outbreaks: Comparison of four bacteriophages Survival of the En-330 veloped Virus Phi6 in Droplets as a Function of Relative Humidity, Absolute Humidity, 331 and Temperature Evaluation of eluents for the recovery of an enveloped virus 334 from hands by whole-hand sampling Effectiveness 337 of Ultraviolet-C Light and a High-Level Disinfection Cabinet for Decontamination of N95 Persistence of Bacteriophage Phi 6 on Porous and Nonporous Surfaces and the 341 Potential for Its Use as an Ebola Virus or Coronavirus Surrogate Coronavirus pathogenesis European Committee for Standardization. Chemical disinfectants and antiseptics -Ap-358 plication of European Standards for chemical disinfectants and antiseptics Disinfectants used for environmental disinfection and new room 362 decontamination technology Increasing 365 Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfac-366 es Stability of SARS-CoV-2 and other corona-368 viruses in the environment and on common touch surfaces and the influence of climatic 369 conditions: A review The effect 371 of temperature and humidity on the stability of SARS-CoV-2 and other enveloped virus-372 es Evaluation of Phi6 Persis-374 tence and Suitability as an Enveloped Virus Surrogate Evaluation of the 393 Effectiveness of Two Automated Room Decontamination Devices Under Real-Life Con-394 ditions The potential impact of ozone on materials in the Gaseous and air decontamination technolo-399 gies for Clostridium difficile in the healthcare environment